Displaying items 881-882 of 882 in total
Starlight is merging its BC multi-family funds. A key regulatory waiver smooths the path, but what does this mean for investors and market governance?
A class action lawsuit against Telix Pharmaceuticals reveals the perilous gap between optimistic corporate disclosures and harsh regulatory setbacks.
Get your daily brief delivered to your inbox every morning at 7am
